Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis

PURPOSE: The combination of hepatitis B immunoglobulin (HBIg) and nucleos(t)ide analogues has been accepted as the best treatment to control hepatitis B recurrence after orthotopic liver transplantation (OLT). However, the optimal dose of HBIg remains unclear. We have previously reported that high-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasunaka, Tetsuya, Takaki, Akinobu, Yagi, Takahito, Iwasaki, Yoshiaki, Sadamori, Hiroshi, Koike, Kazuko, Hirohata, Satoshi, Tatsukawa, Masashi, Kawai, Daisuke, Shiraha, Hidenori, Miyake, Yasuhiro, Ikeda, Fusao, Kobashi, Haruhiko, Matsuda, Hiroaki, Shinoura, Susumu, Yoshida, Ryuichi, Satoh, Daisuke, Utsumi, Masashi, Onishi, Teppei, Yamamoto, Kazuhide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215874/
https://www.ncbi.nlm.nih.gov/pubmed/21484119
http://dx.doi.org/10.1007/s12072-011-9265-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215874/
https://www.ncbi.nlm.nih.gov/pubmed/21484119
http://dx.doi.org/10.1007/s12072-011-9265-z

Ejemplares similares